TRV · Q2 2026 Earnings

Bullish

Travelers Companies (The)

Reported July 17, 2026

30-second summary

Travelers delivered $10.04 of non-GAAP core EPS and $10.26 GAAP diluted EPS on $12.15B of revenue with an 83.6% combined ratio (84.1% underlying) in a quarter that historically carries the year's heaviest CAT load — the $410M after-tax CAT print was ~44% lighter than Q2 FY2025's $732M, letting the underlying machinery show through. The two signals that matter: NII of $883M after-tax beat the $810M Q2 FY2026 guide by ~9% ($73M), and Personal Insurance NWP decline moderated — Q2 FY2026 PI NWP was -7.7% YoY versus Q1 FY2026's -8.7%, a modest improvement (still down, not yet inflected positive), while PI segment revenue was -4.2% YoY. Underneath, the underlying combined ratio held sub-85% for a sixth straight quarter through the seasonally hardest CAT window.

Headline numbers

EPS

Q2 FY2026

$10.04

Revenue

Q2 FY2026

$12.15B

-0.3% YoY

+10.2% vs est.

Key financials

Q2 FY2026

Metric	Q2 FY2026	Q2 FY2025	YoY	Q1 FY2026	QoQ
Revenue	$12.15B	$12.12B	+0.3%	$11.92B	+1.9%
EPS	$10.04	$6.51	+54.2%	$7.71	+30.2%

Guidance

Berkshire Hathaway beat Q2 FY2026 earnings and revenue expectations handily; no forward guidance issued for Q3 or FY2026, leaving future outlook opaque.

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

Actuals vs prior guidance

Metric	Period	Prior guide	Actual	Δ	Result
Net Investment Income (after-tax)	Q2 FY2026	approximately $810 million	$883 million	+$73 million above guide	Beat

Segment performance

Q2 FY2026

Segment	Q2 FY2026	Q2 FY2025	YoY
Business Insurance	$6.543B	$6.413B	+2.0%
Bond & Specialty Insurance	$1.175B	$1.133B	+3.7%
Personal Insurance	$4.375B	$4.564B	-4.1%
Net Written Premiums	$11.525 billion	—	—
Catastrophes, net of reinsurance (after-tax)	$410 million	—	—

Capital & returns

Q2 FY2026

Segment	Q2 FY2026	Q2 FY2025	YoY
Return on Equity	27.1%	20.9%	—
Core Return on Equity	24.9%	18.8%	—

Other KPIs

Q2 FY2026

Segment	Q2 FY2026	Q2 FY2025	YoY
Combined Ratio	83.6%	90.3%	—
Underlying Combined Ratio	84.1%	84.7%	—
Prior Year Reserve Development (after-tax)	$456 million favorable	$249 million favorable	—
Net Investment Income (after-tax)	$883 million	—	—

Management tone

Tone read is based on press release / supplement only, as transcript was not in the source set.

The Q1 FY2026 → Q2 FY2026 arc that the numbers tell: the Personal Insurance decline is moderating, but the inflection thesis is not yet validated. PI NWP was -8.7% YoY in Q1 FY2026 and -7.7% YoY in Q2 FY2026 — a modest improvement, not a positive inflection. Segment revenue was -4.2% YoY in Q2. The Canadian divestiture is washing through the comparison, and the sequential arc is where credibility rebuilds, but PI NWP has not crossed flat and the trajectory to get there is still ahead of management.

The NII trajectory continues to overdeliver. Q2 FY2026 beat its $810M guide by ~9% ($73M). A ~9% beat on a metric management guides quarter-by-quarter is not noise — it either reflects portfolio repricing running structurally ahead of plan, or new-money-yield persistence at higher levels than embedded in the cadence. The Q3 FY2026 cadence of ~$840M looks conservative in light of the $883M Q2 print.

The underlying combined ratio thesis has now survived the Q2 stress test. The Q1 FY2026 brief flagged that Q1's 85.3% underlying ratio broke the sub-85% streak and that Q2 — the heavy-CAT quarter — was the harder credibility test. 84.1% comfortably clears the bar and re-engages the structural margin narrative. The $410M CAT number is well below Q2 FY2025's $732M, so the underlying strip is credible.

Answers to last quarter's watch list

Whether Personal Insurance NWP actually inflects in Q2 FY2026. PI NWP was -7.7% YoY in Q2 FY2026 versus -8.7% in Q1 FY2026 — an improvement in the underlying trajectory but not the flat-or-better inflection the thesis requires. PI segment revenue was -4.2% YoY. The direction of travel matches management's Q1 "encouraging growth momentum" framing, but the segment did not cross flat YoY on either NWP or revenue.

Continue monitoring

Q2 FY2026 underlying combined ratio against the 85.3% Q1 FY2026 baseline. 84.1% — a 120bps improvement QoQ against a heavier-CAT seasonal backdrop. The sub-85% structural margin thesis re-engages cleanly.

Resolved positively

Q2 FY2026 NII delivery against the ~$810M guide. $883M after-tax, +$73M / +9% above the explicit guide, suggesting the portfolio repricing is running ahead of the cadence management laid out.

Resolved positively

Q2 FY2026 share repurchase pace. 4.3M shares repurchased for $1.3B under Board authorization in Q2 FY2026, at the low end of the pre-divestiture $1.3–1.65B range. YTD FY2026 repurchases are $3.1B (10.3M shares). Status: Resolved.

Business Insurance Select RPC trajectory. BI revenue growth decelerated to +2.0% in Q2 FY2026 from +1.7% in Q1 FY2026 (both well below Q4 FY2025's +3.6%) — underlying RPC/rate detail requires the transcript. On the segment-revenue proxy, the softening dynamic Q1 flagged continues.

Continue monitoring

Whether equity-market drawdown lag materializes in Q2 FY2026 alternative investment results. Consolidated after-tax NII of $883M — a beat of $73M versus a guide that already presumably contemplated the alternatives lag — suggests the drawdown impact was more than absorbed by fixed-income strength. Component detail on alternatives specifically would require the transcript. Status: Resolved positively at the consolidated level.

What to watch into next quarter

Whether Q3 FY2026 NII prints materially above the ~$840M cadence. A second consecutive ~9% NII beat would suggest the FY2026 aggregate framing needs to be revised up. A print in the $870M+ range would confirm structural over-delivery.

Personal Insurance NWP crossing flat YoY on a domestic ex-Canada basis. The -7.7% Q2 FY2026 NWP print is not yet the flat-or-better inflection the thesis requires; Q3 FY2026 is the first quarter that could show it cleanly with the Canadian comp receding.

PYD sustainability after the $456M Q2 FY2026 print. The four-quarter run rate has been $16M → $253M → $325M → $456M — trending sharply higher. Watch whether Q3 FY2026 PYD normalizes and whether the $456M reflects a specific line-of-business release worth flagging.

Business Insurance revenue growth stabilizing or continuing to decelerate. The BI arc is now +3.6% (Q4 FY2025) → +1.7% (Q1 FY2026) → +2.0% (Q2 FY2026). Q3 FY2026 needs to hold at 2%+ to avoid confirming a softening trend at odds with management's rate-adequacy framing.

Underlying combined ratio extending the streak in a normalized-CAT Q3 FY2026. 84.1% in a Q2 (heavy CAT) is the stronger structural signal; Q3 FY2026 needs to hold in that neighborhood to confirm the sub-85% operating zone as permanent.

Whether the FY2026 NII aggregate framing gets revised up. The Q2 FY2026 beat trajectory suggests upside to the prior quarterly cadence; watch the next transcript for a refresh.

Sources

Travelers Q2 FY2026 financial supplement, SEC filing — https://www.sec.gov/Archives/edgar/data/86312/000008631226000143/a992finsupp63026.htm
Tapebrief Q1 FY2026, Q4 FY2025, Q3 FY2025, and Q2 FY2025 prior briefs for cross-quarter guidance cadence and trajectory context

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.